Won Chang Won
Department of Family Medicine, College of Medicine, Kyung Hee University, Seoul, Korea.
Korean J Fam Med. 2023 Mar;44(2):71-75. doi: 10.4082/kjfm.22.0224. Epub 2023 Mar 20.
With aging, loss of skeletal muscle mass and muscle function increases, resulting in an increased risk of falls, fractures, long-term institutional care, cardiovascular and metabolic diseases, and even death. Sarcopenia, which is derived from the Greek words "sarx" or flesh+"penia" or loss, is defined as a condition characterized by low muscle mass and low muscle strength and performance. In 2019, the Asian Working Group for Sarcopenia (AWGS) published a consensus paper on the diagnosis and treatment of sarcopenia. The AWGS 2019 guideline, specifically, presented strategies for case-finding and assessment to help diagnose "possible sarcopenia" in primary care settings. For case finding, the AWGS 2019 guideline proposed an algorithm that recommends calf circumference measurement (cut-off <34 cm in men, <33 cm in women) or the SARC-F (strength, assistance with walking, rising from a chair, climbing stairs, and falls) questionnaire (cut-off ≥4). If this case finding is confirmed, handgrip strength (cutoff <28 kg in men, <18 kg in women) or the 5-time chair stand test (≥12 seconds) should be performed to diagnose "possible sarcopenia." If an individual is diagnosed as "possible sarcopenia," AWGS 2019 recommends that the individual should start lifestyle interventions and related health education for primary healthcare users. Because no medication is available to treat sarcopenia, exercise and nutrition is essential for sarcopenia management. Many guidelines, recommend physical activity, with a focus on progressive resistance (strength) training, as a first-line therapy for the management of sarcopenia. It is essential to educate older adults with sarcopenia on the need to increase protein intake. Many guidelines recommended that older people should consume at least 1.2 g of proteins/kg/d. This minimum threshold can be increased in the presence of catabolic or muscle wasting. Previous studies reported that leucine, a branched-chain amino acid, is essential for protein synthesis in muscle, and a stimulator for skeletal muscle synthesis. A guideline conditionally recommends that diet or nutritional supplements should be combined with exercise intervention for older adults with sarcopenia.
随着年龄的增长,骨骼肌质量和肌肉功能的丧失会增加,从而导致跌倒、骨折、长期机构护理、心血管和代谢疾病甚至死亡的风险增加。肌肉减少症源于希腊语“sarx”(意为肉)和“penia”(意为减少),被定义为一种以低肌肉量、低肌肉力量和低肌肉表现为特征的病症。2019年,亚洲肌肉减少症工作组(AWGS)发表了一篇关于肌肉减少症诊断和治疗的共识文件。具体而言,AWGS 2019指南提出了病例发现和评估策略,以帮助在初级保健环境中诊断“可能的肌肉减少症”。对于病例发现,AWGS 2019指南提出了一种算法,建议测量小腿围(男性截断值<34 cm,女性<33 cm)或使用SARC-F问卷(用于评估力量、行走辅助、从椅子上起身、爬楼梯和跌倒情况,截断值≥4)。如果病例发现得到确认,应进行握力测试(男性截断值<28 kg,女性<18 kg)或5次起坐测试(≥12秒)以诊断“可能的肌肉减少症”。如果个体被诊断为“可能的肌肉减少症”,AWGS 2019建议该个体应开始生活方式干预以及针对初级医疗保健使用者的相关健康教育。由于目前没有药物可用于治疗肌肉减少症,运动和营养对于肌肉减少症的管理至关重要。许多指南推荐体育活动,重点是渐进性抗阻(力量)训练,作为肌肉减少症管理的一线治疗方法。对患有肌肉减少症的老年人进行增加蛋白质摄入量必要性的教育至关重要。许多指南建议老年人应每天每千克体重摄入至少1.2克蛋白质。在存在分解代谢或肌肉消耗的情况下,这个最低阈值可以提高。先前的研究报告称,亮氨酸作为一种支链氨基酸,对肌肉中的蛋白质合成至关重要,也是骨骼肌合成的刺激剂。一项指南有条件地建议,对于患有肌肉减少症的老年人,饮食或营养补充剂应与运动干预相结合。